Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Humar

Showing results (161-170 of 235) with videos related to

Pageof 24
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 13, 2019
Cytokine profile in lung transplant recipients with Aspergillus spp colonizationSabina Herrera, Wajiha Gohir, Farid Foroutan, et al.
The Journal of Infectious Diseases|January 16, 2015
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza VaccinationAdrian Egli, Atul Humar, Lukas A Widmer, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 28, 2013
Human cytomegalovirus infection in humanized liver chimeric miceToshiyasu Kawahara, Luiz Filipe Lisboa, Sonia Cader, et al.
Clinical Transplantation|February 19, 2015
Potential role of CC chemokine receptor 6 in prediction of late-onset cytomegalovirus infection following solid organ transplantJose F Camargo, Mariangela R Resende, Ricardo Zamel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 18, 2024
Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023Javier T Solera, Berta G Árbol, Ankit Mittal, et al.
Transplantation Direct|April 1, 2025
Feasibility and Safety of Ex Vivo Delivery of Rituximab to Lung Allografts in Transplant Recipients at High Risk for Epstein-Barr Virus-associated Posttransplant Lymphoproliferative DisorderVictor H Ferreira, Rafaela V P Ribeiro, Faranak Mavandadnejad, et al.
Annals of Internal Medicine|November 22, 2021
Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized TrialDeepali Kumar, Victor H Ferreira, Victoria G Hall, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|December 27, 2007
Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatmentUpton Allen, Caroline Alfieri, Jutta Preiksaitis, et al.
The Lancet. Infectious Diseases|June 23, 2023
Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patientsJavier T Solera, Matthew Ierullo, Berta G Arbol, et al.
Transplantation|January 4, 2011
Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT studyAtul Humar, Ajit P Limaye, Emily A Blumberg, et al.
Pageof 24

Showing results (161-170 of 235) with videos related to

Sort By:
Pageof 24
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 13, 2019
Cytokine profile in lung transplant recipients with Aspergillus spp colonizationSabina Herrera, Wajiha Gohir, Farid Foroutan, et al.
The Journal of Infectious Diseases|January 16, 2015
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza VaccinationAdrian Egli, Atul Humar, Lukas A Widmer, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 28, 2013
Human cytomegalovirus infection in humanized liver chimeric miceToshiyasu Kawahara, Luiz Filipe Lisboa, Sonia Cader, et al.
Clinical Transplantation|February 19, 2015
Potential role of CC chemokine receptor 6 in prediction of late-onset cytomegalovirus infection following solid organ transplantJose F Camargo, Mariangela R Resende, Ricardo Zamel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 18, 2024
Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023Javier T Solera, Berta G Árbol, Ankit Mittal, et al.
Transplantation Direct|April 1, 2025
Feasibility and Safety of Ex Vivo Delivery of Rituximab to Lung Allografts in Transplant Recipients at High Risk for Epstein-Barr Virus-associated Posttransplant Lymphoproliferative DisorderVictor H Ferreira, Rafaela V P Ribeiro, Faranak Mavandadnejad, et al.
Annals of Internal Medicine|November 22, 2021
Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized TrialDeepali Kumar, Victor H Ferreira, Victoria G Hall, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|December 27, 2007
Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatmentUpton Allen, Caroline Alfieri, Jutta Preiksaitis, et al.
The Lancet. Infectious Diseases|June 23, 2023
Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patientsJavier T Solera, Matthew Ierullo, Berta G Arbol, et al.
Transplantation|January 4, 2011
Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT studyAtul Humar, Ajit P Limaye, Emily A Blumberg, et al.
Pageof 24